A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This is a multicenter trial to compare the effectiveness of 4 doses of DR-2021 with placebo
and oral micronized progesterone in inducing withdrawal bleeding in women with secondary
amenorrhea.